APO Research
Talk to an analyst

APO RESEARCH · REPORT

Depression Treatment Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Depression Treatment Device Market Outlook and Growth Opportunities 2026

4 July 2026190 pages

Choose your research edition.

Industry ResearchDepression Treatment Device Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Depression Treatment Device Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Depression Treatment Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Depression Treatment Device Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Depression Treatment Device Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Depression Treatment Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Depression Treatment Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Depression Treatment Device market include Alpha-Stim, BrainsWay, Caputron Medical, Electromedical Products International, Inc., Fisher Wallace Laboratories, Flow Neuroscience, Flow Neuroscience AB, Ginger and INNOVATIVE NEUROLOGICAL Devices LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Depression Treatment Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Depression Treatment Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Depression Treatment Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Depression Treatment Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Depression Treatment Device Segment by Company

Alpha-Stim

BrainsWay

Caputron Medical

Electromedical Products International, Inc.

Fisher Wallace Laboratories

Flow Neuroscience

Flow Neuroscience AB

Ginger

INNOVATIVE NEUROLOGICAL Devices LLC

Magnus Medical

Neurolief

Neuronetics

NeuroStar

The Magstim Company Limited

Depression Treatment Device Segment by Type

Transcranial Direct Current Stimulation (tDCS)

Transcranial Random Noise Stimulation (tRNS)

Transcranial Pulsed Current Stimulation (tPCS)

Transcranial Alternating Current Stimulation (tACS)

Electroconvulsive therapy (ECT)

Others

Depression Treatment Device Segment by Application

Hospital

Clinic

Others

Depression Treatment Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Depression Treatment Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Depression Treatment Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Depression Treatment Device significant trends, drivers, influence factors in global and regions.

6. To analyze Depression Treatment Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Depression Treatment Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Depression Treatment Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Depression Treatment Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Depression Treatment Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Depression Treatment Device industry.

Chapter 3: Detailed analysis of Depression Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Depression Treatment Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Depression Treatment Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Depression Treatment Device Industry Trends Table 2. Depression Treatment Device Industry Drivers Table 3. Depression Treatment Device Industry Opportunities and Challenges Table 4. Depression Treatment Device Industry Restraints Table 5. Global Depression Treatment Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Depression Treatment Device Revenue Share by Company (2021-2026) Table 7. Global Depression Treatment Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Depression Treatment Device Sales Volume Share by Company (2021-2026) Table 9. Global Depression Treatment Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Depression Treatment Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Depression Treatment Device Key Company Manufacturing Base & Headquarters Table 12. Global Depression Treatment Device Company, Product Type & Application Table 13. Global Depression Treatment Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Depression Treatment Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Transcranial Direct Current Stimulation (tDCS) Table 18. Significant Companies of Transcranial Random Noise Stimulation (tRNS) Table 19. Significant Companies of Transcranial Pulsed Current Stimulation (tPCS) Table 20. Significant Companies of Transcranial Alternating Current Stimulation (tACS) Table 21. Significant Companies of Electroconvulsive therapy (ECT) Table 22. Significant Companies of Others Table 23. Global Depression Treatment Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Depression Treatment Device Sales Volume by Type (2021-2026) & (k units) Table 25. Global Depression Treatment Device Sales Volume by Type (2027-2032) & (k units) Table 26. Global Depression Treatment Device Sales Volume Share by Type (2021-2026) Table 27. Global Depression Treatment Device Sales Volume Share by Type (2027-2032) Table 28. Global Depression Treatment Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Depression Treatment Device Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Depression Treatment Device Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Depression Treatment Device Sales Value Share by Type (2021-2026) Table 32. Global Depression Treatment Device Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hospital Table 34. Significant Companies of Clinic Table 35. Significant Companies of Others Table 36. Global Depression Treatment Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Depression Treatment Device Sales Volume by Application (2021-2026) & (k units) Table 38. Global Depression Treatment Device Sales Volume by Application (2027-2032) & (k units) Table 39. Global Depression Treatment Device Sales Volume Share by Application (2021-2026) Table 40. Global Depression Treatment Device Sales Volume Share by Application (2027-2032) Table 41. Global Depression Treatment Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Depression Treatment Device Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Depression Treatment Device Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Depression Treatment Device Sales Value Share by Application (2021-2026) Table 45. Global Depression Treatment Device Sales Value Share by Application (2027-2032) Table 46. Global Depression Treatment Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Depression Treatment Device Sales by Region (2021-2026) & (k units) Table 48. Global Depression Treatment Device Sales Market Share by Region (2021-2026) Table 49. Global Depression Treatment Device Sales by Region (2027-2032) & (k units) Table 50. Global Depression Treatment Device Sales Market Share by Region (2027-2032) Table 51. Global Depression Treatment Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Depression Treatment Device Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Depression Treatment Device Sales Value Share by Region (2021-2026) Table 54. Global Depression Treatment Device Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Depression Treatment Device Sales Value Share by Region (2027-2032) Table 56. Global Depression Treatment Device Market Average Price (USD/unit) by Region (2021-2026) Table 57. Global Depression Treatment Device Market Average Price (USD/unit) by Region (2027-2032) Table 58. Global Depression Treatment Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Depression Treatment Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 61. Global Depression Treatment Device Sales Market Share by Country (2021-2026) Table 62. Global Depression Treatment Device Sales by Country (2027-2032) & (k units) Table 63. Global Depression Treatment Device Sales Market Share by Country (2027-2032) Table 64. Global Depression Treatment Device Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Depression Treatment Device Sales Value Market Share by Country (2021-2026) Table 66. Global Depression Treatment Device Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Depression Treatment Device Sales Value Market Share by Country (2027-2032) Table 68. Alpha-Stim Company Information Table 69. Alpha-Stim Business Overview Table 70. Alpha-Stim Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Alpha-Stim Depression Treatment Device Product Portfolio Table 72. Alpha-Stim Recent Development Table 73. BrainsWay Company Information Table 74. BrainsWay Business Overview Table 75. BrainsWay Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. BrainsWay Depression Treatment Device Product Portfolio Table 77. BrainsWay Recent Development Table 78. Caputron Medical Company Information Table 79. Caputron Medical Business Overview Table 80. Caputron Medical Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Caputron Medical Depression Treatment Device Product Portfolio Table 82. Caputron Medical Recent Development Table 83. Electromedical Products International, Inc. Company Information Table 84. Electromedical Products International, Inc. Business Overview Table 85. Electromedical Products International, Inc. Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Electromedical Products International, Inc. Depression Treatment Device Product Portfolio Table 87. Electromedical Products International, Inc. Recent Development Table 88. Fisher Wallace Laboratories Company Information Table 89. Fisher Wallace Laboratories Business Overview Table 90. Fisher Wallace Laboratories Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Fisher Wallace Laboratories Depression Treatment Device Product Portfolio Table 92. Fisher Wallace Laboratories Recent Development Table 93. Flow Neuroscience Company Information Table 94. Flow Neuroscience Business Overview Table 95. Flow Neuroscience Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Flow Neuroscience Depression Treatment Device Product Portfolio Table 97. Flow Neuroscience Recent Development Table 98. Flow Neuroscience AB Company Information Table 99. Flow Neuroscience AB Business Overview Table 100. Flow Neuroscience AB Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Flow Neuroscience AB Depression Treatment Device Product Portfolio Table 102. Flow Neuroscience AB Recent Development Table 103. Ginger Company Information Table 104. Ginger Business Overview Table 105. Ginger Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Ginger Depression Treatment Device Product Portfolio Table 107. Ginger Recent Development Table 108. INNOVATIVE NEUROLOGICAL Devices LLC Company Information Table 109. INNOVATIVE NEUROLOGICAL Devices LLC Business Overview Table 110. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio Table 112. INNOVATIVE NEUROLOGICAL Devices LLC Recent Development Table 113. Magnus Medical Company Information Table 114. Magnus Medical Business Overview Table 115. Magnus Medical Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Magnus Medical Depression Treatment Device Product Portfolio Table 117. Magnus Medical Recent Development Table 118. Neurolief Company Information Table 119. Neurolief Business Overview Table 120. Neurolief Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Neurolief Depression Treatment Device Product Portfolio Table 122. Neurolief Recent Development Table 123. Neuronetics Company Information Table 124. Neuronetics Business Overview Table 125. Neuronetics Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Neuronetics Depression Treatment Device Product Portfolio Table 127. Neuronetics Recent Development Table 128. NeuroStar Company Information Table 129. NeuroStar Business Overview Table 130. NeuroStar Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. NeuroStar Depression Treatment Device Product Portfolio Table 132. NeuroStar Recent Development Table 133. The Magstim Company Limited Company Information Table 134. The Magstim Company Limited Business Overview Table 135. The Magstim Company Limited Depression Treatment Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. The Magstim Company Limited Depression Treatment Device Product Portfolio Table 137. The Magstim Company Limited Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Depression Treatment Device Distributors List Table 141. Depression Treatment Device Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Depression Treatment Device Product Image Figure 2. Global Depression Treatment Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Depression Treatment Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Depression Treatment Device Sales (2021-2032) & (k units) Figure 5. Global Depression Treatment Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Depression Treatment Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Transcranial Direct Current Stimulation (tDCS) Image Figure 10. Transcranial Random Noise Stimulation (tRNS) Image Figure 11. Transcranial Pulsed Current Stimulation (tPCS) Image Figure 12. Transcranial Alternating Current Stimulation (tACS) Image Figure 13. Electroconvulsive therapy (ECT) Image Figure 14. Others Image Figure 15. Global Depression Treatment Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Depression Treatment Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Depression Treatment Device Sales Volume Share by Type (2021-2032) Figure 18. Global Depression Treatment Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Depression Treatment Device Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Depression Treatment Device Sales Value Share by Type (2021-2032) Figure 21. Hospital Image Figure 22. Clinic Image Figure 23. Others Image Figure 24. Global Depression Treatment Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Depression Treatment Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Depression Treatment Device Sales Volume Share by Application (2021-2032) Figure 27. Global Depression Treatment Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Depression Treatment Device Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Depression Treatment Device Sales Value Share by Application (2021-2032) Figure 30. Global Depression Treatment Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Depression Treatment Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Depression Treatment Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Depression Treatment Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Depression Treatment Device Sales Value (2021-2032) & (US$ Million) Figure 35. North America Depression Treatment Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Depression Treatment Device Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Depression Treatment Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Depression Treatment Device Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Depression Treatment Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Depression Treatment Device Sales Value (2021-2032) & (US$ Million) Figure 41. South America Depression Treatment Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Depression Treatment Device Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Depression Treatment Device Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Depression Treatment Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Depression Treatment Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Depression Treatment Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Depression Treatment Device Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Depression Treatment Device Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Random Noise Stimulation (tRNS)
  • Transcranial Pulsed Current Stimulation (tPCS)
  • Transcranial Alternating Current Stimulation (tACS)
  • Electroconvulsive therapy (ECT)
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Alpha-Stim
  • BrainsWay
  • Caputron Medical
  • Electromedical Products International, Inc.
  • Fisher Wallace Laboratories
  • Flow Neuroscience
  • Flow Neuroscience AB
  • Ginger
  • INNOVATIVE NEUROLOGICAL Devices LLC
  • Magnus Medical
  • Neurolief
  • Neuronetics
  • NeuroStar
  • The Magstim Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Depression Treatment Device Sales Value (2021-2032)
  4. 1.2.2 Global Depression Treatment Device Sales Volume (2021-2032)
  5. 1.2.3 Global Depression Treatment Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Depression Treatment Device Market Dynamics
  1. 2.1 Depression Treatment Device Industry Trends
  2. 2.2 Depression Treatment Device Industry Drivers
  3. 2.3 Depression Treatment Device Industry Opportunities and Challenges
  4. 2.4 Depression Treatment Device Industry Restraints
3 Depression Treatment Device Market by Company
  1. 3.1 Global Depression Treatment Device Company Revenue Ranking in 2025
  2. 3.2 Global Depression Treatment Device Revenue by Company (2021-2026)
  3. 3.3 Global Depression Treatment Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Depression Treatment Device Average Price by Company (2021-2026)
  5. 3.5 Global Depression Treatment Device Company Ranking (2024-2026)
  6. 3.6 Global Depression Treatment Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Depression Treatment Device Company Product Type and Application
  8. 3.8 Global Depression Treatment Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Depression Treatment Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Depression Treatment Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Depression Treatment Device Market by Type
  1. 4.1 Depression Treatment Device Type Introduction
  2. 4.1.1 Transcranial Direct Current Stimulation (tDCS)
  3. 4.1.2 Transcranial Random Noise Stimulation (tRNS)
  4. 4.1.3 Transcranial Pulsed Current Stimulation (tPCS)
  5. 4.1.4 Transcranial Alternating Current Stimulation (tACS)
  6. 4.1.5 Electroconvulsive therapy (ECT)
  7. 4.1.6 Others
  8. 4.2 Global Depression Treatment Device Sales Volume by Type
  9. 4.2.1 Global Depression Treatment Device Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Depression Treatment Device Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Depression Treatment Device Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Depression Treatment Device Sales Value by Type
  13. 4.3.1 Global Depression Treatment Device Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Depression Treatment Device Sales Value by Type (2021-2032)
  15. 4.3.3 Global Depression Treatment Device Sales Value Share by Type (2021-2032)
5 Depression Treatment Device Market by Application
  1. 5.1 Depression Treatment Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Depression Treatment Device Sales Volume by Application
  6. 5.2.1 Global Depression Treatment Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Depression Treatment Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Depression Treatment Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Depression Treatment Device Sales Value by Application
  10. 5.3.1 Global Depression Treatment Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Depression Treatment Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Depression Treatment Device Sales Value Share by Application (2021-2032)
6 Depression Treatment Device Regional Sales and Value Analysis
  1. 6.1 Global Depression Treatment Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Depression Treatment Device Sales by Region (2021-2032)
  3. 6.2.1 Global Depression Treatment Device Sales by Region: 2021-2026
  4. 6.2.2 Global Depression Treatment Device Sales by Region (2027-2032)
  5. 6.3 Global Depression Treatment Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Depression Treatment Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Depression Treatment Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Depression Treatment Device Sales Value by Region (2027-2032)
  9. 6.5 Global Depression Treatment Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Depression Treatment Device Sales Value (2021-2032)
  12. 6.6.2 North America Depression Treatment Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Depression Treatment Device Sales Value (2021-2032)
  15. 6.7.2 Europe Depression Treatment Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Depression Treatment Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Depression Treatment Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Depression Treatment Device Sales Value (2021-2032)
  21. 6.9.2 South America Depression Treatment Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Depression Treatment Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Depression Treatment Device Sales Value Share by Country, 2025 VS 2032
7 Depression Treatment Device Country-level Sales and Value Analysis
  1. 7.1 Global Depression Treatment Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Depression Treatment Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Depression Treatment Device Sales by Country (2021-2032)
  4. 7.3.1 Global Depression Treatment Device Sales by Country (2021-2026)
  5. 7.3.2 Global Depression Treatment Device Sales by Country (2027-2032)
  6. 7.4 Global Depression Treatment Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Depression Treatment Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Depression Treatment Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Depression Treatment Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Depression Treatment Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Depression Treatment Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Depression Treatment Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Depression Treatment Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Depression Treatment Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Depression Treatment Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Depression Treatment Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Depression Treatment Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Depression Treatment Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Depression Treatment Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Depression Treatment Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Depression Treatment Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Depression Treatment Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Depression Treatment Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Depression Treatment Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Depression Treatment Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Depression Treatment Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Depression Treatment Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Depression Treatment Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Depression Treatment Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Depression Treatment Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Depression Treatment Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Depression Treatment Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Depression Treatment Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Depression Treatment Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Depression Treatment Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Depression Treatment Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Depression Treatment Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Depression Treatment Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alpha-Stim
  2. 8.1.1 Alpha-Stim Company Information
  3. 8.1.2 Alpha-Stim Business Overview
  4. 8.1.3 Alpha-Stim Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alpha-Stim Depression Treatment Device Product Portfolio
  6. 8.1.5 Alpha-Stim Recent Developments
  7. 8.2 BrainsWay
  8. 8.2.1 BrainsWay Company Information
  9. 8.2.2 BrainsWay Business Overview
  10. 8.2.3 BrainsWay Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BrainsWay Depression Treatment Device Product Portfolio
  12. 8.2.5 BrainsWay Recent Developments
  13. 8.3 Caputron Medical
  14. 8.3.1 Caputron Medical Company Information
  15. 8.3.2 Caputron Medical Business Overview
  16. 8.3.3 Caputron Medical Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Caputron Medical Depression Treatment Device Product Portfolio
  18. 8.3.5 Caputron Medical Recent Developments
  19. 8.4 Electromedical Products International, Inc.
  20. 8.4.1 Electromedical Products International, Inc. Company Information
  21. 8.4.2 Electromedical Products International, Inc. Business Overview
  22. 8.4.3 Electromedical Products International, Inc. Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Electromedical Products International, Inc. Depression Treatment Device Product Portfolio
  24. 8.4.5 Electromedical Products International, Inc. Recent Developments
  25. 8.5 Fisher Wallace Laboratories
  26. 8.5.1 Fisher Wallace Laboratories Company Information
  27. 8.5.2 Fisher Wallace Laboratories Business Overview
  28. 8.5.3 Fisher Wallace Laboratories Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fisher Wallace Laboratories Depression Treatment Device Product Portfolio
  30. 8.5.5 Fisher Wallace Laboratories Recent Developments
  31. 8.6 Flow Neuroscience
  32. 8.6.1 Flow Neuroscience Company Information
  33. 8.6.2 Flow Neuroscience Business Overview
  34. 8.6.3 Flow Neuroscience Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Flow Neuroscience Depression Treatment Device Product Portfolio
  36. 8.6.5 Flow Neuroscience Recent Developments
  37. 8.7 Flow Neuroscience AB
  38. 8.7.1 Flow Neuroscience AB Company Information
  39. 8.7.2 Flow Neuroscience AB Business Overview
  40. 8.7.3 Flow Neuroscience AB Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Flow Neuroscience AB Depression Treatment Device Product Portfolio
  42. 8.7.5 Flow Neuroscience AB Recent Developments
  43. 8.8 Ginger
  44. 8.8.1 Ginger Company Information
  45. 8.8.2 Ginger Business Overview
  46. 8.8.3 Ginger Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ginger Depression Treatment Device Product Portfolio
  48. 8.8.5 Ginger Recent Developments
  49. 8.9 INNOVATIVE NEUROLOGICAL Devices LLC
  50. 8.9.1 INNOVATIVE NEUROLOGICAL Devices LLC Company Information
  51. 8.9.2 INNOVATIVE NEUROLOGICAL Devices LLC Business Overview
  52. 8.9.3 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio
  54. 8.9.5 INNOVATIVE NEUROLOGICAL Devices LLC Recent Developments
  55. 8.10 Magnus Medical
  56. 8.10.1 Magnus Medical Company Information
  57. 8.10.2 Magnus Medical Business Overview
  58. 8.10.3 Magnus Medical Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Magnus Medical Depression Treatment Device Product Portfolio
  60. 8.10.5 Magnus Medical Recent Developments
  61. 8.11 Neurolief
  62. 8.11.1 Neurolief Company Information
  63. 8.11.2 Neurolief Business Overview
  64. 8.11.3 Neurolief Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Neurolief Depression Treatment Device Product Portfolio
  66. 8.11.5 Neurolief Recent Developments
  67. 8.12 Neuronetics
  68. 8.12.1 Neuronetics Company Information
  69. 8.12.2 Neuronetics Business Overview
  70. 8.12.3 Neuronetics Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Neuronetics Depression Treatment Device Product Portfolio
  72. 8.12.5 Neuronetics Recent Developments
  73. 8.13 NeuroStar
  74. 8.13.1 NeuroStar Company Information
  75. 8.13.2 NeuroStar Business Overview
  76. 8.13.3 NeuroStar Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 NeuroStar Depression Treatment Device Product Portfolio
  78. 8.13.5 NeuroStar Recent Developments
  79. 8.14 The Magstim Company Limited
  80. 8.14.1 The Magstim Company Limited Company Information
  81. 8.14.2 The Magstim Company Limited Business Overview
  82. 8.14.3 The Magstim Company Limited Depression Treatment Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 The Magstim Company Limited Depression Treatment Device Product Portfolio
  84. 8.14.5 The Magstim Company Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Depression Treatment Device Value Chain Analysis
  2. 9.1.1 Depression Treatment Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Depression Treatment Device Sales Mode & Process
  6. 9.2 Depression Treatment Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Depression Treatment Device Distributors
  9. 9.2.3 Depression Treatment Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst